Cresco Labs Inc
CNSX:CL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cresco Labs Inc
CNSX:CL
|
US |
|
KYN Capital Group Inc
OTC:KYNC
|
US |
|
Mycelx Technologies Corp
LSE:MYX
|
US |
|
H
|
Hang Xanh Motors Service JSC
VN:HAX
|
VN |
|
H
|
Hydrogenone Capital Growth PLC
LSE:HGEN
|
UK |
|
V
|
Vitrolife AB
SWB:VTFN
|
SE |
|
M
|
Menif Financial Services Ltd
TASE:MNIF
|
IL |
Wall Street
Price Targets
CL Price Targets Summary
Cresco Labs Inc
According to Wall Street analysts, the average 1-year price target for CL is 2.19 CAD with a low forecast of 2.02 CAD and a high forecast of 2.36 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CL's stock price target?
Price Target
2.19
CAD
According to Wall Street analysts, the average 1-year price target for CL is 2.19 CAD with a low forecast of 2.02 CAD and a high forecast of 2.36 CAD.
What is Cresco Labs Inc's Revenue forecast?
Projected CAGR
3%
The compound annual growth rate of Cresco Labs Inc's revenue for the next 3 years is 3%.
What is Cresco Labs Inc's Operating Income forecast?
Projected CAGR
14%
The compound annual growth rate of Cresco Labs Inc's operating income for the next 3 years is 14%.